This paper is only available as a PDF. To read, Please Download here.
Abstract
To provide a venue to allow for the exchange of information among parties interested
in pharmacoeconoic research opportunities within managed-care organizations, an invitational
conference was conducted by The University of Arizona's Center for Pharmaceutical
Economics on January 20 and 21, 1994, in Tucson, Arizona. The purpose of the conference
was to bring together representative from managed-care organizations, academic institutions,
and the pharmaceutical industry to discuss opportunities for collaboration, as well
as consider the barriers to conducting pharmacoeconomic research in the managed-care
setting. Challenges to collaboration include database development, the need for an
integrated perspective, sensitivity to marketing matters, and a variety of technical
and organizational barriers. To overcome these barriers, the interested groups must
develop trust, recognize common ground, share risk, and communicate effectively. This
article describes the emerging themes of the conference based on transcripts of formal
presentations and participants' comments.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Clinical TherapeuticsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Introduction to pharmacoeconomics.in: Bootman JL Townsend RJ McGhan WF Principles of Pharmacoeconomics. Harvey Whitney Books Company, Cincinnati1991: 4
- Economic, clinical, and humanistic outcomes: A planning model for pharmacoeconomic research.Clin Ther. 1993; 15: 1121-1132
Article info
Identification
Copyright
© 1995 Published by Elsevier Inc.
